HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure.
Saved in:
| Title: | HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. |
|---|---|
| Authors: | Ow SY; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Kapp EA; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Tomasetig V; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Zalewski A; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Simmonds J; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Panousis C; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Wilson MJ; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Nash AD; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia., Pelzing M; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia. |
| Source: | MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2163459. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36628468 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ow+SY%22">Ow SY</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Kapp+EA%22">Kapp EA</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Tomasetig+V%22">Tomasetig V</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Zalewski+A%22">Zalewski A</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Simmonds+J%22">Simmonds J</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Panousis+C%22">Panousis C</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Wilson+MJ%22">Wilson MJ</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Nash+AD%22">Nash AD</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Pelzing+M%22">Pelzing M</searchLink>; Research and Development, CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101479829%22">MAbs</searchLink> [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2163459. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101479829 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1942-0870 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219420862%22">19420862 </searchLink><i>NLM ISO Abbreviation: </i>MAbs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36628468 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/19420862.2022.2163459 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2163459 Titles: – TitleFull: HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ow SY – PersonEntity: Name: NameFull: Kapp EA – PersonEntity: Name: NameFull: Tomasetig V – PersonEntity: Name: NameFull: Zalewski A – PersonEntity: Name: NameFull: Simmonds J – PersonEntity: Name: NameFull: Panousis C – PersonEntity: Name: NameFull: Wilson MJ – PersonEntity: Name: NameFull: Nash AD – PersonEntity: Name: NameFull: Pelzing M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2023 Jan-Dec Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1942-0870 Numbering: – Type: volume Value: 15 – Type: issue Value: 1 Titles: – TitleFull: MAbs Type: main |
| ResultId | 1 |